Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Histopathology and spatial transcriptomics jointly map myofiber-specific pathological programs in mTORC1-driven myopathy
Jer-En Hsu, Qingyang Zhao, Weiqiu Cheng, Hyun Min Kang, Susan V. Brooks, Myungjin Kim, Jun Hee Lee
Jer-En Hsu, Qingyang Zhao, Weiqiu Cheng, Hyun Min Kang, Susan V. Brooks, Myungjin Kim, Jun Hee Lee
View: Text | PDF
Research Article Cell biology Muscle biology

Histopathology and spatial transcriptomics jointly map myofiber-specific pathological programs in mTORC1-driven myopathy

  • Text
  • PDF
Abstract

Skeletal muscle is composed of heterogeneous myofiber types and non-myocyte populations. Myopathies occur in many diseases, but the mechanisms driving these pathologies remain largely unknown, partly because conventional approaches cannot link histopathological features to molecular states at single-fiber resolution. To address this challenge, we brought histopathology and spatial transcriptomics together by applying high-resolution Seq-Scope technology to a mouse model of mTORC1 hyperactivation. Cross-sections from the extensor digitorum longus (EDL) and soleus (SOL), two muscles with distinct fiber-type compositions, were profiled to determine how transcriptome changes are linked to histopathological outcomes. mTORC1 hyperactivation elicited distinct, fiber type–dependent pathological programs. Type I and IIa fibers were largely resistant to mTORC1-induced pathology, exhibiting relatively limited morphological alterations. In contrast, type IIx fibers diverged into opposing fates: in SOL, they underwent abnormal enlargement associated with sustained growth signaling, cytoskeletal remodeling, and impaired proteostasis; in EDL, they developed basophilia associated with increased RNA content and lipid-, oxidative-, and nucleotide metabolism–related signatures. Within EDL, type IIb fibers displayed heterogeneity with discrete transcriptional states. Non-myocytic populations, including macrophages and fibroblasts, accumulated preferentially in SOL, forming a fibrotic microenvironment associated with inflammation, remodeling, and hypertrophy. These findings provide a link between histopathological phenotypes and molecular states at single-fiber resolution.

Authors

Jer-En Hsu, Qingyang Zhao, Weiqiu Cheng, Hyun Min Kang, Susan V. Brooks, Myungjin Kim, Jun Hee Lee

×

Figure 1

Seq-Scope enables histopathology-guided single-myofiber transcriptome analysis.

Options: View larger image (or click on image) Download as PowerPoint
Seq-Scope enables histopathology-guided single-myofiber transcriptome an...
(A) Schematic of the experimental workflow. Arrows indicate pathological phenotypes including basophilia (white), hypertrophy (black), and central nuclei (green). H&E histology, DAPI/WGA imaging, and Seq-Scope whole transcriptome analysis were performed on the same slide, which allowed precise segmentation and single-myofiber transcriptome analysis. Scale bar: 50 μm. (B) Cross-sections of control and mutant skeletal muscles examined by Seq-Scope. From top to bottom, images are displayed as H&E histology, DAPI/WGA staining, RNA density map from Seq-Scope transcriptome data, single-myofiber segmentation, and spatial myofiber type projection, according to the clusters identified in C. Tsc1fl/fl Depdc5fl/fl: control; Ckm-Cre Tsc1fl/fl Depdc5fl/fl: mutant. MF1: myofiber type I; MF2A: myofiber type IIa; MF2X: myofiber type IIx; MF2B: myofiber type IIb. Scale bars: 1 mm and 50 μm. (C) UMAP manifolds displaying the major myofiber types identified by multidimensional clustering. Datasets were integrated across mice. Each point (n = 8,616) represents an individual myofiber and is colored according to its corresponding myofiber type (center) or its originating muscle depot (lower right). (D) UMAP manifold colored by the expression levels of myosin heavy chain (Myh) isoforms that represent each myofiber type. (E) Pathological phenotypes observed in mTORC1 hyperactivated skeletal muscle. Left panel: centrally nucleated myofibers (arrows in the top row) and hypertrophic fibers (arrows in the bottom row). Right panel: transitional basophilic fibers (top row, scattered dark particles) and developed basophilic fibers (bottom row, dense and strip-like filling). Boxed areas are magnified on the right. Scale bars: 12 μm and 50 μm. (F) Quantification of pathological phenotype prevalence by muscle depot (left) or by myofiber type (right). “Other” includes myofibers from control muscles as well as morphologically normal fibers from mutant muscles. CTRL, control; KO, mutant.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts